These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 18473295

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Irbesartan treatment in hypertension.
    Brown MJ.
    Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
    [Abstract] [Full Text] [Related]

  • 25. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S, Komers R.
    N Engl J Med; 2008 Sep 04; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract] [Full Text] [Related]

  • 26. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct 04; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV.
    Future Cardiol; 2009 Sep 04; 5(5):453-65. PubMed ID: 19715410
    [Abstract] [Full Text] [Related]

  • 30. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML, Patterson JH.
    Pharmacotherapy; 1996 Sep 04; 16(5):849-60. PubMed ID: 8888079
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 04; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin-II receptor antagonists: their place in therapy.
    Kirk JK.
    Am Fam Physician; 1999 Jun 04; 59(11):3140-8. PubMed ID: 10392595
    [Abstract] [Full Text] [Related]

  • 34. Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?
    Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH.
    J Hypertens; 2011 Dec 04; 29(12):2454-61. PubMed ID: 22002336
    [Abstract] [Full Text] [Related]

  • 35. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F, Krzesinski JM, Piérard L, Scheen AJ.
    Rev Med Liege; 2008 Apr 04; 63(4):174-81. PubMed ID: 18575070
    [Abstract] [Full Text] [Related]

  • 36. [Theoretical background of angiotensin II receptor blockade and its features in clinical pharmacology].
    Winkler G, Jermendy G, Matos L.
    Orv Hetil; 2003 Sep 07; 144(36):1763-8. PubMed ID: 14579673
    [Abstract] [Full Text] [Related]

  • 37. Hypertension and valsartan.
    Kızılırmak P, Üresin AY.
    Anadolu Kardiyol Derg; 2014 Dec 07; 14 Suppl 2():S20-4. PubMed ID: 25604204
    [Abstract] [Full Text] [Related]

  • 38. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
    Kuwabara Y, Komuro I.
    Nihon Naika Gakkai Zasshi; 2005 Feb 10; 94(2):255-61. PubMed ID: 15768589
    [No Abstract] [Full Text] [Related]

  • 39. From black and white to shades of gray: race and renin-angiotensin system blockade.
    Havranek EP.
    J Am Coll Cardiol; 2008 May 13; 51(19):1872-3. PubMed ID: 18466802
    [No Abstract] [Full Text] [Related]

  • 40. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan.
    Yilmaz MI, Saglam M, Sonmez A, Caglar K, Cakir E, Kurt Y, Eyileten T, Tasar M, Acikel C, Oguz Y, Vural A, Yenicesu M.
    Blood Purif; 2007 May 13; 25(4):327-35. PubMed ID: 17709915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.